FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management


RPT 300
Volume 238

Cover Page

Letter from CFSAN to Hyman, Phelps, & McNamara, P.C.

Letter from Hyman, Phelps, & McNamara, P.C. to CFSAN

NDI Submission for Kakuda Plum Concentrate

Appendix 1 - Australian TGA Listing for Kakadu Plum Concentrate Published Material

Appendix 2 - Office of Complementary Medicines, Therapeutic Goods Administration (2003). Evaluation of a new listable substance, Terminalia ferdinandiana (Kakadu plum). (Confidential unpublished TGA report).

Appendix 3 - Confidential Kakadu Plum Concentrate Analyses and Methods

Appendix 4 - Confidential "Kakadu Plum Products in the Market & Estimated Fruit Intake"

Appendix 5 - Results of scientific literature search, continued

References Published Material

Top | Back

Page last updated January 3, 2006 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management